Bureaucrats, developer, Administrators
9,842
edits
User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 13:27, 16 July 2020
, 16 July 2020→Brain cancer: + a 2010 study published in w:PLOS One on w:astrocytomas and cannabis receptors on 'The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas'
m (→Brain cancer and cannabis: readded info that was removed by the revert) |
(→Brain cancer: + a 2010 study published in w:PLOS One on w:astrocytomas and cannabis receptors on 'The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas') |
||
| Line 218: | Line 218: | ||
* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]] | * [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]] | * [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 '''comparative study''', published in [[w:Neurochemistry International]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/20090845 'The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 study published in [[w:PLOS One]] on [[w:astrocytomas]] and cannabis receptors | |||
* [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | * [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | ||